Concepedia

Olivier Pétricoul

OP

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

2001

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Novartis (China)

Charité - Universitätsmedizin Berlin

Olivier Pétricoul is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and pharmacotherapy.

Publications per year

2001–2022

11

Publications

11

Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity

Steven B. Heymsfield, Laura A. Coleman, Ram R. Miller et al. · JAMA Network Open · 2021 · 301 citations · Full text

, , +17

Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study

Daniel Rooks, Jens Præstgaard, Sam Hariry et al. · Journal of the American Geriatrics Society · 2017 · 228 citations

, , +17

Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity

Thomas Dörner, Maximilian Posch, Yue Li et al. · Annals of the Rheumatic Diseases · 2019 · 200 citations

, , +17

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults

Daniel Rooks, Therese Swan, Budhaditya Goswami et al. · JAMA Network Open · 2020 · 160 citations · Full text

, , +17

Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

Tania Garito, Ronenn Roubenoff, Marcus Hompesch et al. · Diabetes Obesity and Metabolism · 2017 · 86 citations

, , +17

1–5 of 11